Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O5XJ
|
|||
| Former ID |
DCL001258
|
|||
| Drug Name |
XL652/XL014
|
|||
| Indication | Cardiovascular disease [ICD-11: BA00-BE2Z] | Phase 1 | [1] | |
| Metabolic disorder [ICD-11: 5C50-5D2Z] | Phase 1 | [1] | ||
| Company |
Exelixis; Bristol-Myers Squibb
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Oxysterols receptor LXR (NR1H) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Exelixis (2011). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.